Clinical Trials Browser

Phase EARLY_PHASE1 × Recruiting × Lymphoma, Large B-Cell, Diffuse × Clear all

NCT04512716 2026-02-17

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Phase EARLY_PHASE1 Recruiting

Lymphoma, Large B-Cell, Diffuse, Pyloric Stenosis, Hypertrophic

NCT05800405 2026-02-04

Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

Phase EARLY_PHASE1 Recruiting

Lymphoma, Large B-Cell, Diffuse

NCT06120166 2025-09-19

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research

Phase EARLY_PHASE1 Recruiting

Lymphoma, Large B-Cell, Diffuse